Inoue, T.; Naitoh, I.; Kitano, R.; Ibusuki, M.; Kobayashi, Y.; Sumida, Y.; Nakade, Y.; Ito, K.; Yoneda, M.
Endobiliary Radiofrequency Ablation Combined with Gemcitabine and Cisplatin in Patients with Unresectable Extrahepatic Cholangiocarcinoma. Curr. Oncol. 2022, 29, 2240-2251.
https://doi.org/10.3390/curroncol29040182
AMA Style
Inoue T, Naitoh I, Kitano R, Ibusuki M, Kobayashi Y, Sumida Y, Nakade Y, Ito K, Yoneda M.
Endobiliary Radiofrequency Ablation Combined with Gemcitabine and Cisplatin in Patients with Unresectable Extrahepatic Cholangiocarcinoma. Current Oncology. 2022; 29(4):2240-2251.
https://doi.org/10.3390/curroncol29040182
Chicago/Turabian Style
Inoue, Tadahisa, Itaru Naitoh, Rena Kitano, Mayu Ibusuki, Yuji Kobayashi, Yoshio Sumida, Yukiomi Nakade, Kiyoaki Ito, and Masashi Yoneda.
2022. "Endobiliary Radiofrequency Ablation Combined with Gemcitabine and Cisplatin in Patients with Unresectable Extrahepatic Cholangiocarcinoma" Current Oncology 29, no. 4: 2240-2251.
https://doi.org/10.3390/curroncol29040182
APA Style
Inoue, T., Naitoh, I., Kitano, R., Ibusuki, M., Kobayashi, Y., Sumida, Y., Nakade, Y., Ito, K., & Yoneda, M.
(2022). Endobiliary Radiofrequency Ablation Combined with Gemcitabine and Cisplatin in Patients with Unresectable Extrahepatic Cholangiocarcinoma. Current Oncology, 29(4), 2240-2251.
https://doi.org/10.3390/curroncol29040182